Here are the latest quarterly results of Suven Life Sciences. For more details, see the Suven Life Sciences financial fact sheet and Suven Life Sciences share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-18 |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,290 | 2,533 | 1,990 | 2,743 | 28 | 87 | 14 | 90 | |
Other income | Rs m | 58 | 38 | 30 | 56 | 59 | 30 | 25 | 23 | |
Turnover | Rs m | 1,348 | 2,571 | 2,020 | 2,799 | 86 | 117 | 40 | 113 | |
Expenses | Rs m | 934 | 1,480 | 1,090 | 1,638 | 121 | 107 | 92 | 128 | |
Gross profit | Rs m | 356 | 1,053 | 900 | 1,105 | -94 | -21 | -78 | -38 | |
Depreciation | Rs m | 56 | 55 | 56 | 56 | 9 | 11 | 11 | 11 | |
Interest | Rs m | 5 | 16 | 13 | 19 | 1 | 2 | 2 | 3 | |
Profit before tax | Rs m | 352 | 1,020 | 862 | 1,087 | -45 | -4 | -65 | -29 | |
Tax | Rs m | 100 | 340 | 290 | 364 | 0 | 22 | -25 | -10 | |
Profit after tax | Rs m | 252 | 680 | 572 | 723 | -45 | -26 | -41 | -19 | |
Gross profit margin | % | 27.6 | 41.6 | 45.2 | 40.3 | -337.6 | -24.0 | -545.1 | -42.8 | |
Effective tax rate | % | 28.4 | 33.4 | 33.7 | 33.5 | -0.9 | -602.5 | 37.7 | 34.4 | |
Net profit margin | % | 19.6 | 26.8 | 28.7 | 26.4 | -162.3 | -29.6 | -285.4 | -21.1 | |
Diluted EPS | Rs | 2.0 | 5.3 | 4.5 | 5.7 | -0.4 | -0.2 | -0.3 | -0.1 | |
Diluted EPS (TTM) | Rs | 11.4 | 11.8 | 13.2 | 17.5 | 15.2 | 9.6 | 4.8 | -1.0 | |
![]() |
Read: Suven Life Sciences 1QFY20 Result Performance Review
More Pharmaceuticals Company Quarterly Results: ALEMBIC WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA UNICHEM LAB
Compare SUVEN LIFE SCIENCES With: ALEMBIC WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA UNICHEM LAB
Compare SUVEN LIFE SCIENCES With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.
Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.
For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More